NCT03862378 Prediction of Intra-abdominal Infectious Complication by Drainage Fluid Analysis Status UNKNOWN Phase N/A
NCT03858855 Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment Status COMPLETED Phase NA
NCT03850912 Symptom Management Implementation of Patient Reported Outcomes in Oncology Status COMPLETED Phase NA
NCT03828266 Prediction of Abdominal Complications After GastroEnterological Surgery Status UNKNOWN Phase N/A
NCT03745326 Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients Status TERMINATED Phase PHASE1/PHASE2
NCT03723447 Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Status COMPLETED Phase PHASE4
NCT03699332 Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin Status UNKNOWN Phase PHASE1/PHASE2
NCT03665714 Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer Status COMPLETED Phase NA
NCT03631537 Nutrition-support-team Based Intervention in Patients With Advanced Gastrointestinal Cancer Status UNKNOWN Phase NA
NCT03611309 Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members Status COMPLETED Phase NA
NCT03602677 Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage Status UNKNOWN Phase NA
NCT03597581 A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer Status COMPLETED Phase PHASE1
NCT03531320 Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase Status COMPLETED Phase PHASE1/PHASE2
NCT03515941 Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers Status TERMINATED Phase EARLY_PHASE1
NCT03507998 Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors Status UNKNOWN Phase PHASE1
NCT03480152 Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer Status TERMINATED Phase PHASE1/PHASE2